EPM Shares Eclipse Metals Limited
ASX · ASXLast in our picks 2026-10-23 — not in the current list; analysis below is from that screen
US clinical enrollment and platform expansion create meaningful upside ahead of commercialisation.
Signal breakdown
- ▸DETECT study enrollment reached 50 participants, supporting execution momentum.
- ▾Below 50-day MA (-18.15%)
- ▾Near 52-week low (0% of range)
Is EPM a buy right now?
Trend: EPM is trading above the 50-day average (+15.00%), RSI 39 — neutral momentum, with a 3-month return of -17.86%.
Valuation & quality: Eclipse Metals Limited trades on price-to-book 1.83; fundamentals show net margin 0.0%, return on equity -11.4%, revenue growth 440.8% year on year.
Our screen: WATCH (score 0) — US clinical enrollment and platform expansion create meaningful upside ahead of commercialisation.
Computed from end-of-day data; not personal advice.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| +0.00% | +0.00% | -50.00% | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
Fundamentals
Technical signals
About Eclipse Metals Limited
Eclipse Metals Limited, together with its subsidiaries, engages in the exploration, evaluation, and development of mineral properties in Australia and Greenland.
Sector: Basic Materials · Industry: Other Industrial Metals & Mining · Australia · Website
Related Biotech picks
Browse: all ASX stocks · Biotech picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.